Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Dialysis continuous

Remove unreacted NHS-fluorescein and reaction by-products by gel filtration or dialysis. Continue to protect all labeled protein solutions from light. [Pg.405]

Dialysis continues to meet certain specialized applications, particularly those in biotechnology and the life sciences. Delicate substances can be separated without damage because dialysis is typically performed under mild conditions ambient temperature, no appreciable transmembrane pressure drop, and low-shear flow. While slow compared with pressure-driven processes, dialysis discriminates small molecules from large ones reliably because the absence of a pressure gradient across the membrane prevents convective flow through defects in the membrane. This advantage is significant for two... [Pg.389]

Indications Peritoneal dialysis (continuous, ambulatory) Category Dialysis solution Half-life N/A... [Pg.290]

These experiments were aimed to determine three variables for optimization of this process 1) What should be the initial dialysate osmolality in order to prevent hemolysis 2) What is the fastest rate at which the osmolality may be lowered without hemolysis 3) How long should dialysis continue before the glycerol is at acceptable levels (< 200 mosm) ... [Pg.116]

Semama DS, Huet F, Gouyon JB, et al. 1995. Use of peritoneal dialysis, continuous arteriovenous hemofiltration, and continuous arteriovenous hemodiafiltration for removal of ammonium chloride and glutamine in rabbits. J Pediatr 126 742-746. [Pg.213]

Figure 7.42 Schematic of dialysate-feed, immobilized cell system for dialysis continuous fermentation.86... Figure 7.42 Schematic of dialysate-feed, immobilized cell system for dialysis continuous fermentation.86...
The most striking and important difference between nondialysis and dialysis continuous culture is the much higher cell concentration attainable in dialysis culture, especially at low dilution rates. Further, it is seen that the maximum production rate in continuous dialysis culture is achieved at a lower dilution rate than in nondialysis continuous culture. This effect, however, is reached at the expense of lower efficiencies in converting substrate to cells. [Pg.375]

A diffusion mechanism is also used in dialysis as a means of separating colloids from crystalloids. The rate of diffusion of molecules in gels is practically the same as in water, indicating the continuous nature of the aqueous phase. The diffusion of gases into a stream of vapour is of considerable importance in diffusion pumps. [Pg.137]

Electrodialysis. In electro dialysis (ED), the saline solution is placed between two membranes, one permeable to cations only and the other to anions only. A direct electrical current is passed across this system by means of two electrodes, causiag the cations ia the saline solution to move toward the cathode, and the anions to the anode. As shown ia Figure 15, the anions can only leave one compartment ia their travel to the anode, because a membrane separating them from the anode is permeable to them. Cations are both excluded from one compartment and concentrated ia the compartment toward the cathode. This reduces the salt concentration ia some compartments, and iacreases it ia others. Tens to hundreds of such compartments are stacked together ia practical ED plants, lea ding to the creation of alternating compartments of fresh and salt-concentrated water. ED is a continuous-flow process, where saline feed is continuously fed iato all compartments and the product water and concentrated brine flow out of alternate compartments. [Pg.251]

R. Gokal, Continuous Ambulatoy Peritoneal Dialysis, Churchill Livingston, Edinburgh, 1987. [Pg.38]

Figure 2.5 Possible technological solutions to bioprocess problems a) Fed-batch culture b) Continuous product removal (eg dialysis, vacuum fermentation, solvent extraction, ion exchange etc) c) Two-phase system combined with extractive fermentation (liquid-impelled loop reactor) d) Continuous culture, internal multi-stage reactor e) Continuous culture, dual-stream multi-stage reactor f) Continuous culture with biomass feedback (cell recycling). (See text for further details). Figure 2.5 Possible technological solutions to bioprocess problems a) Fed-batch culture b) Continuous product removal (eg dialysis, vacuum fermentation, solvent extraction, ion exchange etc) c) Two-phase system combined with extractive fermentation (liquid-impelled loop reactor) d) Continuous culture, internal multi-stage reactor e) Continuous culture, dual-stream multi-stage reactor f) Continuous culture with biomass feedback (cell recycling). (See text for further details).
While it would be difficult to enumerate all of the efforts in the area of implants where plastics are involved, some of the significant ones are (1) the implanted pacemaker, (2) the surgical prosthesis devices to replace lost limbs, (3) the use of plastic tubing to support damaged blood vessels, and (4) the work with the portable artificial kidney. The kidney application illustrates an area where more than the mechanical characteristics of the plastics are used. The kidney machine consists of large areas of a semi-permeable membrane, a cellulosic material in some machines, where the kidney toxins are removed from the body fluids by dialysis based on the semi-permeable characteristics of the plastic membrane. A number of other plastics are continually under study for use in this area, but the basic unit is a device to circulate the body fluid through the dialysis device to separate toxic substances from the blood. The mechanical aspects of the problem are minor but do involve supports for the large amount of membrane required. [Pg.259]

In the dialyzed batch start-up phase and the subsequent continuous operation a substantial increase in viable cell density and monoclonal antibody (MAb) titer was observed compared to a conventional suspension culture. The raw data, profiles of the viable cell density, viability and monoclonal antibody titer during the batch start-up and the continuous operation with a dialysis flow rate of 5 L/d are shown in Figures 17.6 and 17.7. The raw data are also available in tabular form in the corresponding input file for the FORTRAN program on data smoothing for short cut methods provided with the enclosed CD. [Pg.331]

Figure 17.6 Dialyzed Chemostat Monoclonal antibody concentration (raw and smoothed measurements) during initial batch start-up and subsequent dialyzed continuous operation with a dialysis flow rate of 5 L/d. [reprinted from the Journal of Biotechnology Bioengineering with permission from J. Wiley],... Figure 17.6 Dialyzed Chemostat Monoclonal antibody concentration (raw and smoothed measurements) during initial batch start-up and subsequent dialyzed continuous operation with a dialysis flow rate of 5 L/d. [reprinted from the Journal of Biotechnology Bioengineering with permission from J. Wiley],...
With either type of dialysis, studies suggest that recovery of renal function is decreased in ARF patients who undergo dialysis compared with those not requiring dialysis. Decreased recovery of renal function may be due to hemodialysis-induced hypotension causing additional ischemic injury to the kidney. Also, exposure of a patient s blood to bioincompatible dialysis membranes (cuprophane or cellulose acetate) results in complement and leukocyte activation which can lead to neutrophil infiltration into the kidney and release of vasoconstrictive substances that can prolong renal dysfunction.26 Synthetic membranes composed of substances such as polysulfone, polyacrylonitrile, and polymethylmethacrylate are considered to be more biocompatible and would be less likely to activate complement. Synthetic membranes are generally more expensive than cellulose-based membranes. Several recent meta-analyses found no difference in mortality between biocompatible and bioincompatible membranes. Whether biocompatible membranes lead to better patient outcomes continues to be debated. [Pg.368]

Freedom from the "machine" gives the patient a sense of independence (for continuous ambulatory peritoneal dialysis). [Pg.395]

Peritoneal dialysis (PD) utilizes similar principles as hemodialysis in that blood is exposed to a semipermeable membrane against which a physiologic solution is placed. In the case of PD, however, the semipermeable membrane is the peritoneal membrane, and a sterile dialysate is instilled into the peritoneal cavity. The peritoneal membrane is composed of a continuous single layer of mesothelial cells that covers the abdominal and pelvic walls on one side of the peritoneal cavity, and the visceral organs, including the GI tract, liver, spleen, and diaphragm on the other side. The mesothelial cells are covered by microvilli that increase the surface area of the peritoneal membrane to approximate body surface area (1 to 2 m2). [Pg.397]

Primary peritonitis generally is caused by a single organism (.Staphylococcus aureus in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and Escherichia coli in patients with cirrhosis). [Pg.1129]

O Primary peritonitis develops in up to 25% of patients with alcoholic cirrhosis.3 Patients undergoing continuous ambulatory peritoneal dialysis (CAPD) average one episode of peritonitis every 2 years.4 Secondary peritonitis may be caused by perforation of a peptic ulcer traumatic perforation of the stomach, small or large bowel, uterus, or urinary bladder appendicitis pancreatitis diverticulitis bowel infarction inflammatory bowel disease cholecystitis operative contamination of the peritoneum or diseases of the female genital tract such as septic abortion, postoperative uterine infection, endometritis, or salpingitis. Appendicitis is one of the most common causes of intraabdominal infection. In 1998, 278,000 appendectomies were performed in the United States for suspected appendicitis.5... [Pg.1130]

Intraperitoneal (IP) administration of antibiotics is preferred over IV therapy in the treatment of peritonitis that occurs in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The International Society of Peritoneal Dialysis (ISPD) recently revised its guidelines for the diagnosis and pharmacotherapy of peritoneal dialysis (PD)-associated infections.24 The guidelines provide dosing recommendations for intermittent and continuous therapy based on the modality of dialysis [CAPD or automated peritoneal dialysis (APD)] and the extent of the patient s residual renal function. [Pg.1134]


See other pages where Dialysis continuous is mentioned: [Pg.337]    [Pg.142]    [Pg.211]    [Pg.207]    [Pg.65]    [Pg.337]    [Pg.142]    [Pg.211]    [Pg.207]    [Pg.65]    [Pg.50]    [Pg.165]    [Pg.514]    [Pg.252]    [Pg.185]    [Pg.34]    [Pg.87]    [Pg.311]    [Pg.409]    [Pg.337]    [Pg.350]    [Pg.405]    [Pg.574]    [Pg.511]    [Pg.531]    [Pg.330]    [Pg.334]    [Pg.368]    [Pg.398]    [Pg.401]    [Pg.401]    [Pg.831]    [Pg.1134]    [Pg.1137]   
See also in sourсe #XX -- [ Pg.967 ]

See also in sourсe #XX -- [ Pg.967 ]

See also in sourсe #XX -- [ Pg.967 ]




SEARCH



Continuous ambulant peritoneal dialysis

Continuous ambulatory peritoneal dialysis

Continuous ambulatory peritoneal dialysis CAPD)

Continuous cycling peritoneal dialysis

Dialysis

Dialysis apparatus, continuous

© 2024 chempedia.info